|
1
|
Minturn JE, Fryer HJ, Geschwind DH and
Hockfield S: TOAD-64, a gene expressed early in neuronal
differentiation in the rat, is related to unc-33, a C.
elegans gene involved in axon outgrowth. J Neurosci.
15:6757–6766. 1995.PubMed/NCBI
|
|
2
|
Hamajima N, Matsuda K, Sakata S, Tamaki N,
Sasaki M and Nonaka M: A novel gene family defined by human
dihydropyrimidinase and three related proteins with differential
tissue distribution. Gene. 180:157–163. 1996. View Article : Google Scholar
|
|
3
|
Byk T, Dobransky T, Cifuentes-Diaz C and
Sobel A: Identification and molecular characterization of
Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of
the axonal guidance-associated unc-33 gene product. J Neurosci.
16:688–701. 1996.
|
|
4
|
Quinn CC, Gray GE and Hockfield S: A
family of proteins implicated in axon guidance and outgrowth. J
Neurobiol. 41:158–164. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Byk T, Ozon S and Sobel A: The Ulip family
phosphoproteins-common and specific properties. Eur J Biochem.
254:14–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Horiuchi M, El Far O and Betz H: Ulip6, a
novel unc-33 and dihydropyrimidinase related protein highly
expressed in developing rat brain. FEBS Lett. 480:283–286. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fukada M, Watakabe I, Yuasa-Kawada J, et
al: Molecular characterization of CRMP5, a novel member of the
collapsin response mediator protein family. J Biol Chem.
275:37957–37965. 2000. View Article : Google Scholar
|
|
8
|
Inatome R, Tsujimura T, Hitomi T, et al:
Identification of CRAM, a novel unc-33 gene family protein that
associates with CRMP3 and protein-tyrosine kinase(s) in the
developing rat brain. J Biol Chem. 275:27291–27302. 2000.
|
|
9
|
Li W, Herman RK and Shaw JE: Analysis of
the Caenorhabditis elegans axonal guidance and outgrowth
gene unc-33. Genetics. 132:675–689. 1992.
|
|
10
|
Quach TT, Duchemin AM, Rogemond V, et al:
Involvement of collapsin response mediator proteins in the neurite
extension induced by neurotrophins in dorsal root ganglion neurons.
Mol Cell Neurosci. 25:433–443. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uchida Y, Ohshima T, Sasaki Y, et al:
Semaphorin3A signalling is mediated via sequential Cdk5 and
GSK3beta phosphorylation of CRMP2: implication of common
phosphorylating mechanism underlying axon guidance and Alzheimer’s
disease. Genes Cells. 10:165–179. 2005.PubMed/NCBI
|
|
12
|
Fukata Y, Itoh TJ, Kimura T, et al: CRMP-2
binds to tubulin heterodimers to promote microtubule assembly. Nat
Cell Biol. 4:583–591. 2002.PubMed/NCBI
|
|
13
|
Cole AR, Causeret F, Yadirgi G, et al:
Distinct priming kinases contribute to differential regulation of
collapsin response mediator proteins by glycogen synthase kinase-3
in vivo. J Biol Chem. 281:16591–16598. 2006. View Article : Google Scholar
|
|
14
|
Hotta A, Inatome R, Yuasa-Kawada J, Qin Q,
Yamamura H and Yanagi S: Critical role of collapsin response
mediator protein-associated molecule CRAM for filopodia and growth
cone development in neurons. Mol Biol Cell. 16:32–39. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goshima Y, Nakamura F, Strittmatter P and
Strittmatter SM: Collapsin-induced growth cone collapse mediated by
an intracellular protein related to UNC-33. Nature. 376:509–514.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uchida Y and Goshima Y: Molecular
mechanism of axon guidance mediated by phosphorylation of CRMP2.
Seikagaku. 77:1424–1427. 2005.(In Japanese).
|
|
17
|
Yoshimura T, Kawano Y, Arimura N, Kawabata
S and Kaibuchi K: Molecular mechanisms of neuronal polarity. Nihon
Shinkei Seishinhin Yakurigaku Zasshi. 25:169–174. 2005.(In
Japanese).
|
|
18
|
Lin PC, Chan PM, Hall C and Manser E:
Collapsin response mediator proteins (CRMPs) are a new class of
microtubule-associated protein (MAP) that selectively interacts
with assembled microtubules via a taxol-sensitive binding
interaction. J Biol Chem. 286:41466–41478. 2011. View Article : Google Scholar
|
|
19
|
Yoshimura T, Arimura N, Kawano Y, Kawabata
S, Wang S and Kaibuchi K: Ras regulates neuronal polarity via the
PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway. Biochem Biophys Res
Commun. 340:62–68. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshimura T, Kawano Y, Arimura N, Kawabata
S, Kikuchi A and Kaibuchi K: GSK-3beta regulates phosphorylation of
CRMP-2 and neuronal polarity. Cell. 120:137–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lykissas MG, Batistatou AK,
Charalabopoulos KA and Beris AE: The role of neurotrophins in
axonal growth, guidance, and regeneration. Curr Neurovasc Res.
4:143–151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moolenaar WH: Development of our current
understanding of bioactive lysophospholipids. Ann N Y Acad Sci.
905:1–10. 2000. View Article : Google Scholar
|
|
23
|
Chun J, Weiner JA, Fukushima N, et al:
Neurobiology of receptor-mediated lysophospholipid signaling. From
the first lysophospholipid receptor to roles in nervous system
function and development. Ann N Y Acad Sci. 905:110–117. 2000.
View Article : Google Scholar
|
|
24
|
Arimura N, Inagaki N, Chihara K, et al:
Phosphorylation of collapsin response mediator protein-2 by
Rho-kinase. Evidence for two separate signaling pathways for growth
cone collapse. J Biol Chem. 275:23973–23980. 2000. View Article : Google Scholar
|
|
25
|
Patrakitkomjorn S, Kobayashi D, Morikawa
T, et al: Neurofibromatosis type 1 (NF1) tumor suppressor,
neurofibromin, regulates the neuronal differentiation of PC12 cells
via its associating protein, CRMP-2. J Biol Chem. 283:9399–9413.
2008. View Article : Google Scholar
|
|
26
|
Shih JY, Yang SC, Hong TM, et al:
Collapsin response mediator protein-1 and the invasion and
metastasis of cancer cells. J Natl Cancer Inst. 93:1392–1400. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen JJ, Peck K, Hong TM, et al: Global
analysis of gene expression in invasion by a lung cancer model.
Cancer Res. 61:5223–5230. 2001.PubMed/NCBI
|
|
28
|
Shih JY, Lee YC, Yang SC, Hong TM, Huang
CY and Yang PC: Collapsin response mediator protein-1: a novel
invasion-suppressor gene. Clin Exp Metastasis. 20:69–76. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu CC, Lin JC, Yang SC, et al: Modulation
of the expression of the invasion-suppressor CRMP-1 by
cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and
C/EBPalpha. Mol Cancer Ther. 7:1365–1375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khuri FR, Wu H, Lee JJ, et al:
Cyclooxygenase-2 overexpression is a marker of poor prognosis in
stage I non-small cell lung cancer. Clin Cancer Res. 7:861–867.
2001.PubMed/NCBI
|
|
31
|
Riedl K, Krysan K, Põld M, et al:
Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist
Updat. 7:169–184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Masferrer JL, Leahy KM, Koki AT, et al:
Antiangiogenic and antitumor activities of cyclooxygenase-2
inhibitors. Cancer Res. 60:1306–1311. 2000.PubMed/NCBI
|
|
33
|
Grösch S, Tegeder I, Niederberger E,
Bräutigam L and Geisslinger G: COX-2 independent induction of cell
cycle arrest and apoptosis in colon cancer cells by the selective
COX-2 inhibitor celecoxib. FASEB J. 15:2742–2744. 2001.
|
|
34
|
Yao M, Lam EC, Kelly CR, Zhou W and Wolfe
MM: Cyclooxygenase-2 selective inhibition with NS-398 suppresses
proliferation and invasiveness and delays liver metastasis in
colorectal cancer. Br J Cancer. 90:712–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie D, Nakachi K, Wang H, Elashoff R and
Koeffler HP: Elevated levels of connective tissue growth factor,
WISP-1, and CYR61 in primary breast cancers associated with more
advanced features. Cancer Res. 61:8917–8923. 2001.
|
|
36
|
Wenger C, Ellenrieder V, Alber B, Lacher
U, et al: Expression and differential regulation of connective
tissue growth factor in pancreatic cancer cells. Oncogene.
18:1073–1080. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kubo M, Kikuchi K, Nashiro K, et al:
Expression of fibrogenic cytokines in desmoplastic malignant
melanoma. Br J Dermatol. 139:192–197. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shakunaga T, Ozaki T, Ohara N, et al:
Expression of connective tissue growth factor in cartilaginous
tumors. Cancer. 89:1466–1473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang CC, Shih JY, Jeng YM, et al:
Connective tissue growth factor and its role in lung adenocarcinoma
invasion and metastasis. J Natl Cancer Inst. 96:364–375. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan SH, Chao YC, Hung PF, et al: The
ability of LCRMP-1 to promote cancer invasion by enhancing
filopodia formation is antagonized by CRMP-1. J Clin Invest.
121:3189–3205. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan SH, Chao YC, Chen HY, et al: Long form
collapsin response mediator protein-1 (LCRMP-1) expression is
associated with clinical outcome and lymph node metastasis in
non-small cell lung cancer patients. Lung Cancer. 67:93–100. 2010.
View Article : Google Scholar
|
|
42
|
Wang WL, Hong TM, Chang YL, Wu CT, Pan SH
and Yang PC: Phosphorylation of LCRMP-1 by GSK3beta promotes
filopodia formation, migration and invasion abilities in lung
cancer cells. PLoS One. 7:e316892012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu CC, Chen HC, Chen SJ, et al:
Identification of collapsin response mediator protein-2 as a
potential marker of colorectal carcinoma by comparative analysis of
cancer cell secretomes. Proteomics. 8:316–332. 2008. View Article : Google Scholar
|
|
44
|
Oliemuller E, Peláez R, Garasa S, et al:
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker
and candidate therapeutic target for NSCLC. Int J Cancer.
132:1986–1995. 2013. View Article : Google Scholar
|
|
45
|
Shimada K, Ishikawa T, Nakamura F, et al:
Collapsin response mediator protein 2 is involved in regulating
breast cancer progression. Breast Cancer. Feb 5–2013.(Epub ahead of
print).
|
|
46
|
Goodyear S and Sharma MC: Roscovitine
regulates invasive breast cancer cell (MDA-MB231) proliferation and
survival through cell cycle regulatory protein cdk5. Exp Mol
Pathol. 82:25–32. 2007. View Article : Google Scholar
|
|
47
|
Upadhyay AK, Ajay AK, Singh S and Bhat MK:
Cell cycle regulatory protein 5 (Cdk5) is a novel downstream target
of ERK in carboplatin induced death of breast cancer cells. Curr
Cancer Drug Targets. 8:741–752. 2008. View Article : Google Scholar
|
|
48
|
Prasad CP, Rath G, Mathur S, Bhatnagar D,
Parshad R and Ralhan R: Expression analysis of E-cadherin, Slug and
GSK3beta in invasive ductal carcinoma of breast. BMC Cancer.
9:3252009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao X, Pang J, Li LY, et al: Expression
profiling identifies new function of collapsin response mediator
protein 4 as a metastasis-suppressor in prostate cancer. Oncogene.
29:4555–4566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rosslenbroich V, Dai L, Baader SL, Noegel
AA, Gieselmann V and Kappler J: Collapsin response mediator
protein-4 regulates F-actin bundling. Exp Cell Res. 310:434–444.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hiroshima Y, Nakamura F, Miyamoto H, et
al: Collapsin response mediator protein 4 expression is associated
with liver metastasis and poor survival in pancreatic cancer. Ann
Surg Oncol. 20(Suppl 3): S369–S378. 2013. View Article : Google Scholar
|
|
52
|
Gaetano C, Matsuo T and Thiele CJ:
Identification and characterization of a retinoic acid-regulated
human homologue of the unc-33-like phosphoprotein gene (hUlip) from
neuroblastoma cells. J Biol Chem. 272:12195–12201. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Choi YL, Kim CJ, Matsuo T, et al: HUlip, a
human homologue of unc-33-like phosphoprotein of Caenorhabditis
elegans; Immunohistochemical localization in the developing
human brain and patterns of expression in nervous system tumors. J
Neurooncol. 73:19–27. 2005.PubMed/NCBI
|
|
54
|
Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ
and Li Z: Dihydropyrimidinase-like protein 3 expression is
negatively regulated by MYCN and associated with clinical outcome
in neuroblastoma. Cancer Sci. 104:1586–1592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Quinn CC, Chen E, Kinjo TG, et al: TUC-4b,
a novel TUC family variant, regulates neurite outgrowth and
associates with vesicles in the growth cone. J Neurosci.
23:2815–2823. 2003.PubMed/NCBI
|
|
56
|
Yuasa-Kawada J, Suzuki R, Kano F, Ohkawara
T, Murata M and Noda M: Axonal morphogenesis controlled by
antagonistic roles of two CRMP subtypes in microtubule
organization. Eur J Neurosci. 17:2329–2343. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yu Z, Kryzer TJ, Griesmann GE, Kim K,
Benarroch EE and Lennon VA: CRMP-5 neuronal autoantibody: marker of
lung cancer and thymoma-related autoimmunity. Ann Neurol.
49:146–154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Monstad SE, Drivsholm L, Skeie GO, Aarseth
JH and Vedeler CA: CRMP5 antibodies in patients with small-cell
lung cancer or thymoma. Cancer Immunol Immunother. 57:227–232.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Asamura H, Kameya T, Matsuno Y, et al:
Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin
Oncol. 24:70–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Meyronet D, Massoma P, Thivolet F, et al:
Extensive expression of collapsin response mediator protein 5
(CRMP5) is a specific marker of high-grade lung neuroendocrine
carcinoma. Am J Surg Pathol. 32:1699–1708. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lacroix M, Abi-Said D, Fourney DR, et al:
A multivariate analysis of 416 patients with glioblastoma
multiforme: prognosis, extent of resection, and survival. J
Neurosurg. 95:190–198. 2001. View Article : Google Scholar
|
|
62
|
Liang Y, Diehn M, Watson N, et al: Gene
expression profiling reveals molecularly and clinically distinct
subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA.
102:5814–5819. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Brot S, Rogemond V, Perrot V, et al: CRMP5
interacts with tubulin to inhibit neurite outgrowth, thereby
modulating the function of CRMP2. J Neurosci. 30:10639–10654. 2010.
View Article : Google Scholar : PubMed/NCBI
|
